- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x IMD: IMIDAZOLE(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 3 residues within 4Å:- Chain A: G.56, T.58
- Chain C: Y.51
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.58
GOL.3: 11 residues within 4Å:- Chain A: F.169, P.170, V.172, S.180, L.181, S.182
- Chain B: Q.166, E.167, S.168, S.182, T.184
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:E.167, B:S.168, B:S.182, A:S.182, A:S.182
GOL.7: 2 residues within 4Å:- Chain B: R.60, V.64
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.60, B:V.64
- 13 x ZN: ZINC ION(Non-covalent)
ZN.4: 3 residues within 4Å:- Chain A: E.151, A.171
- Ligands: IMD.1
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:E.151
ZN.5: 2 residues within 4Å:- Chain A: D.62
- Chain B: D.1
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.62
ZN.8: 2 residues within 4Å:- Chain B: D.157, H.195
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.157, B:H.195
ZN.9: 4 residues within 4Å:- Chain A: H.167, T.186
- Chain B: N.143, N.144
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:H.167
ZN.10: 3 residues within 4Å:- Chain B: S.188, D.191
- Ligands: IMD.6
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:D.191
ZN.11: 2 residues within 4Å:- Chain B: E.61, S.62
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:E.61, B:E.61, H2O.1
ZN.12: 3 residues within 4Å:- Chain B: Q.85, A.86, E.87
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.87, B:E.87
ZN.13: 1 residues within 4Å:- Chain B: D.9
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:D.9
ZN.14: 3 residues within 4Å:- Chain A: K.132
- Chain B: N.216, E.219
No protein-ligand interaction detected (PLIP)ZN.15: 2 residues within 4Å:- Chain A: H.167
- Chain B: D.173
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:D.173, B:D.173
ZN.16: 1 residues within 4Å:- Chain B: E.167
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:E.167
ZN.17: 2 residues within 4Å:- Chain B: K.155, E.201
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.201, B:E.201
ZN.24: 5 residues within 4Å:- Chain C: R.34, S.36, H.38, E.46, K.95
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:H.38, C:E.46
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 2 residues within 4Å:- Chain C: N.19, Y.80
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.19, C:Y.80
NAG.19: 3 residues within 4Å:- Chain C: Y.85, V.86, N.87
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.87
NAG.20: 1 residues within 4Å:- Chain C: N.111
No protein-ligand interaction detected (PLIP)NAG.21: 2 residues within 4Å:- Chain C: N.53, Q.57
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Q.57
- Hydrogen bonds: C:Q.57
NAG.22: 3 residues within 4Å:- Chain C: N.27, N.74, E.75
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.27, C:N.74
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majocchi, S. et al., NI-3201 is a bispecific antibody mediating PD-L1-dependent CD28 costimulation on T cells for enhanced tumor control. Cancer Immunology Research (2024)
- Release Date
- 2024-12-18
- Peptides
- Heavy chain Fab fragment of AI3 antibody: A
Light chain of AI3 antibody: B
T-cell-specific surface glycoprotein CD28: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x IMD: IMIDAZOLE(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 13 x ZN: ZINC ION(Non-covalent)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majocchi, S. et al., NI-3201 is a bispecific antibody mediating PD-L1-dependent CD28 costimulation on T cells for enhanced tumor control. Cancer Immunology Research (2024)
- Release Date
- 2024-12-18
- Peptides
- Heavy chain Fab fragment of AI3 antibody: A
Light chain of AI3 antibody: B
T-cell-specific surface glycoprotein CD28: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
F